NM_000128.4:c.1853T>G
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PP2PP3_StrongPP5
The NM_000128.4(F11):c.1853T>G(p.Ile618Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000304 in 1,614,002 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I618V) has been classified as Uncertain significance.
Frequency
Consequence
NM_000128.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| F11 | ENST00000403665.7 | c.1853T>G | p.Ile618Ser | missense_variant | Exon 15 of 15 | 1 | NM_000128.4 | ENSP00000384957.2 | ||
| F11-AS1 | ENST00000505103.5 | n.844A>C | non_coding_transcript_exon_variant | Exon 3 of 4 | 1 | |||||
| F11 | ENST00000264691.4 | c.452T>G | p.Ile151Ser | missense_variant | Exon 3 of 3 | 3 | ENSP00000264691.4 | |||
| F11 | ENST00000503841.1 | n.372T>G | non_coding_transcript_exon_variant | Exon 2 of 2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152140Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000796 AC: 2AN: 251404 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.0000315 AC: 46AN: 1461862Hom.: 0 Cov.: 31 AF XY: 0.0000330 AC XY: 24AN XY: 727236 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152140Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74310 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:1Other:1
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 19652879, 16835901, 15953011) -
- -
Hereditary factor XI deficiency disease Pathogenic:1
Variant summary: F11 c.1853T>G (p.Ile618Ser), also reported as I600S, results in a non-conservative amino acid change located in the Serine proteases, trypsin domain (IPR001254) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 8e-06 in 251404 control chromosomes. c.1853T>G has been reported in the literature in the heterozygous state in 2 individuals and in the homozygous state in 1 individual affected with Hereditary factor XI deficiency disease (example, Mitchell_2005, Hill_2005). These data indicate that the variant is likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in <10% of normal FXI:C coagulant activity in the homozygous state and 23-60% FXI:C coagulant activity in the heterozygous state (example, Mitchell_2005, Hill_2005), consistent with possible dominant negative effects. The following publications have been ascertained in the context of this evaluation (PMID: 15953011, 16835901). ClinVar contains an entry for this variant (Variation ID: 68190). Based on the evidence outlined above, the variant was classified as pathogenic. -
F11-related disorder Pathogenic:1
The F11 c.1853T>G variant is predicted to result in the amino acid substitution p.Ile618Ser. This variant, also referred to as c.1896T>G (p.Ile600Ser), has previously been reported to be causative for Hemophilia C (see patient IDs 033061 and 5964 in Mitchell et al. 2006. PubMed ID: 16835901; family 12 in Hill et al. 2005. PubMed ID: 15953011). In Mitchell et al., patient 033061 was homozygous for the c.1853T>G variant and exhibited <2% normal FXI protein activity compared to patient 5946 which was heterozygous for the variant and exhibited 23% FXI activity. Acquired disease states including liver disease, may also alter FXI activity. This variant is reported in 0.0018% of alleles in individuals of European (Non-Finnish) descent in gnomAD. This variant is interpreted as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at